Amanote Research

Amanote Research

    RegisterSign In

FDA Eyes Pharmacogenomics Data.

Environmental Health Perspectives - United States
doi 10.1289/ehp.112-1316888
Full Text
Open PDF
Abstract

Available in full text

Categories
MutagenesisPublic HealthEnvironmentalHealthToxicologyOccupational Health
Date

March 1, 2004

Authors
Julie Wakefield
Publisher

Environmental Health Perspectives


Related search

Clinical Pharmacogenomics

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2018English

Pediatric Pharmacogenomics

Pediatric Clinics of North America
Child HealthPediatricsPerinatology
2012English

Cancer Pharmacogenomics

Pathology
Forensic MedicinePathology
2020English

Chapter 7: Pharmacogenomics

PLoS Computational Biology
Molecular NeuroscienceEvolutionEcologyGeneticsBehaviorMolecular BiologySystematicsSimulationCellularComputational TheoryMathematicsModeling
2012English

VKORC1 Pharmacogenomics Summary

Pharmacogenetics and Genomics
Molecular MedicineGeneticsMolecular Biology
2010English

Rheumatoid Arthritis Pharmacogenomics

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2010English

FDA on Overseas Data: US Drag Market to Open Up?

Nature
Multidisciplinary
1982English

Pharmacogenomics Foreword 2020

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2020English

FDA Pressure?

Nature
Multidisciplinary
1990English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy